Report Feature
The future of the global diagnostic specialty antibody market looks promising with opportunities in hospitals and diagnostic laboratories. The global diagnostic specialty antibody market is expected to grow with a CAGR of 4%-6% from 2020 to 2025. The major drivers for this market are surge in government investment in diagnostic health care and increase in launch of new and innovative biologic diagnostic kits.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global diagnostic specialty antibody market report, please download the report brochure.
In this market, monoclonal antibodies is the fastest growing antibody type of diagnostic specialty antibody, whereas hospitals is the fastst growing end user. Growth in various segments of the diagnostic specialty antibody market are given below:
The study includes trends and forecast for the global diagnostic specialty antibodies market by antibody type, application, end user, and region as follows:
By Antibody Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Polyclonal Antibodies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Hepatitis Diagnosis
Tuberculosis Diagnostics
Dengue Diagnostics
Oncology Diagnostics
HIV Diagnostics
Infectious Disease Diagnostics
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals
Diagnostic Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
Spain
Italy
France
Asia Pacific
China
Japan
India
The Rest of the World
Brazil
Some of the diagnostic specialty antibodies companies profiled in this report include Abcam, Sanofi, Abbott laboratories, Hoffmann-La Roche, Danaher, Bio-Rad Laboratories, Boehringer Ingelheim International, Agilent Technologies, and Aytu BioScience.
Lucintel forecasts that monoclonal antibodies will remain the largest antibody type segment over the forecast period, as monoclonal antibodies play a vital role in the diagnosis of many infectious and chronic diseases, such as cancer. Also, an increase in the importance of monoclonal antibodies in scientific research for generation is projected to boost this segment over the forecast period.
Within this market, hospitals will remain the largest end user segment over the forecast period. Increase in the number of infectious diseases and rise in prevalence of cancer and HIV infections are likely to boost the segment during the forecast period.
North America will remain the largest region over the forecast period. Recent advancemants in diagnostic specialty antibody diagnostics, reimbursement for disease screening, and improved access to diagnostics are the major drivers of the diagnostic specialty antibody market in North America.
|
Features of the Global Diagnostic Specialty Antibody Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global diagnostic specialty antibody market by antibody type (monoclonal antibodies, polyclonal antibodies, and recombinant polyclonal antibodies), application (hepatitis diagnosis, tuberculosis diagnostics, dengue diagnostics, oncology diagnostics, HIV diagnostics, and infectious disease diagnostics), end user (hospitals and diagnostic laboratories), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global diagnostic specialty antibody market? Q.5 What are the business risks and threats to the global diagnostic specialty antibody market? Q.6 What are the emerging trends in this diagnostic specialty antibody market and the reasons behind them? Q.7 What are some changing demands of customers in this diagnostic specialty antibody market? Q.8 What are the new developments in this diagnostic specialty antibody market? Which companies are leading these developments? Q.9 Who are the major players in this diagnostic specialty antibody market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this diagnostic specialty antibody market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global diagnostic specialty antibody market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments |
Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies), Application (Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics), and End User (Hospitals and Diagnostic Laboratories) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (Germany, United Kingdom, Spain, Italy, and France), Asia (China, Japan, and India), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Diagnostic Specialty Antibody Market
4.1 Global Diagnostic Specialty Antibody Market by Region
4.2.1 Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.2.2 Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.2.3 Market by End User: Hospitals and Diagnostic Laboratories
4.2.4 The United States Diagnostic Specialty Antibody Market
4.2.5 The Canadian Diagnostic Specialty Antibody Market
4.2.6 The Mexican Diagnostic Specialty Antibody Market
4.3.1 Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.3.2 Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.3.3 Market by End User: Hospitals and Diagnostic Laboratories
4.3.4 The German Diagnostic Specialty Antibody Market
4.3.5 The United Kingdom Diagnostic Specialty Antibody Market
4.3.6 The Spain Diagnostic Specialty Antibody Market
4.3.7 The Italy Diagnostic Specialty Antibody Market
4.3.8 The French Diagnostic Specialty Antibody Market
4.4.1 Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.4.2 Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.4.3 Market by End User: Hospitals and Diagnostic Laboratories
4.4.4 The Chinese Diagnostic Specialty Antibody Market
4.4.5 The Indian Diagnostic Specialty Antibody Market
4.4.6 The Japanese Diagnostic Specialty Antibody Market
4.5.1 Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.5.2 Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.5.3 Market by End User: Hospitals and Diagnostic Laboratories
4.5.4 Brazilian Diagnostic Specialty Antibody Market
7.1.1 Growth Opportunities for the Global Diagnostic Specialty Antibody Market by Antibody Type
7.1.2 Growth Opportunities for the Global Diagnostic Specialty Antibody Market by Application
7.1.3 Growth Opportunities for the Global Diagnostic Specialty Antibody Market by End User
7.1.4 Growth Opportunities for the Global Diagnostic Specialty Antibody Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
